Burrage Capital Management LLC

CIK

1796461

Location

BOSTON, MA

Portfolio Value

Micro $62,339,402

Diversification

Diversified

Filing Date

Global Rank

#4,844 / 5,928 ▼ 263 · as of Jun 2021

Top Industry

Biotechnology 62.5%

3Y Alpha vs SPY

-4.8%

Period ended 5 years ago

Filed Aug 16, 2021 · 4y

6 quarters · since Mar 2020

Clone Performance

Jul 2023–Jul 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio

+80.3%

SPY

+76.5%

Annualised alpha

+0.9%

Max drawdown

−42.9%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

12 positions · as of Jun 30, 2021 · Δ vs Mar 31, 2021

Top Position

21.9%

+8.9 pts

Top 5

65.9%

+12.8 pts

Top 10

95.3%

+12.0 pts

HHI

1,201

Diversified+366

Portfolio Trend

6 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2021

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$62,339,402	12

Last Quarter's Activity

Export CSV

Jun 30, 2021 vs Mar 31, 2021

Added To

Positions the filer increased

1 positions

Ticker	Company	Δ Shares	Shares	Value	Open
CRNX	Crinetics Pharmaceuticals, Inc.	+22,227	294,620	$5,553,587
No positions match the current search.

Trimmed

Positions the filer reduced

No qualifying positions this quarter.

New Positions

Positions the filer opened this quarter

2 positions

Ticker	Company	Shares	Value
FOLD	AMICUS THERAPEUTICS, INC.	500,000	$4,820,000
RVMD	Revolution Medicines, Inc.	50,000	$1,587,000
No positions match the current search.

Sold Out

Positions the filer fully exited

4 positions

Ticker	Company	Shares	Value
PLX	Protalix BioTherapeutics, Inc.	2,125,585	$9,480,109
PTCT	Ptc Therapeutics, Inc.	160,372	$7,593,614
FULC	Fulcrum Therapeutics, Inc.	319,819	$3,767,467
APLS	Apellis Pharmaceuticals, Inc.	80,727	$3,463,995
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

12 positions · $62,339,402 total · as of Jun 30, 2021

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
BCRX	Biocryst Pharmaceuticals Inc Healthcare	Held	864,916	0	$13,674,321	+55.5%	21.94%
NTLA	Intellia Therapeutics, Inc. Healthcare	Held	63,634	0	$10,302,980	+101.7%	16.53%
NEO	Neogenomics Inc Healthcare	Held	147,921	0	$6,681,591	−6.3%	10.72%
CRNX	Crinetics Pharmaceuticals, Inc. Healthcare	Added	294,620	+22,227	$5,553,587	+33.4%	8.91%
CYTK	Cytokinetics Inc Healthcare	Held	244,673	0	$4,842,078	−14.9%	7.77%
FOLD	AMICUS THERAPEUTICS, INC. Healthcare	NEW	500,000	NEW	$4,820,000	NEW	7.73%
HRMY	Harmony Biosciences Holdings, Inc. Healthcare	Held	150,000	0	$4,234,500	−14.6%	6.79%
MIRM	Mirum Pharmaceuticals, Inc. Healthcare	Held	205,866	0	$3,559,423	−12.8%	5.71%
ADCT	ADC Therapeutics SA Healthcare	Held	124,875	0	$3,040,706	−0.2%	4.88%
GERN	Geron Corp Healthcare	Held	1,912,673	0	$2,696,868	−10.8%	4.33%
RVMD	Revolution Medicines, Inc. Healthcare	NEW	50,000	NEW	$1,587,000	NEW	2.55%
BDTX	Black Diamond Therapeutics, Inc. Healthcare	Held	110,447	0	$1,346,348	−49.8%	2.16%